Breast magnetic resonance imaging (MRI) is the most sensitive imaging modality for breast
cancer diagnosis and is widely used clinically. Dynamic contrast-enhanced MRI is the basis …

Breast cancer is a known heterogeneous disease. Current clinically utilized histopathologic
biomarkers may undersample tumor heterogeneity, resulting in higher rates of misdiagnosis …

Background For breast cancer patients undergoing neoadjuvant chemotherapy (NAC),
pathologic complete response (pCR; no invasive or in situ) cannot be assessed non …

Background Previous studies have suggested that texture analysis is a promising tool in the
diagnosis, characterization, and assessment of treatment response in various cancer types …

Background The purpose of this study was to investigate the value of wavelet-transformed
radiomic MRI in predicting the pathological complete response (pCR) to neoadjuvant …

We performed a systematic review and a meta-analysis of studies using MRI-radiomics for
predicting the pathological complete response in breast cancer patients undergoing …

Purpose MRI-based tumor response prediction to neoadjuvant systemic therapy (NST) in
breast cancer patients is increasingly being studied using radiomics with outcomes that …

Background This study was conducted in order to develop a model for predicting response
to neoadjuvant chemotherapy (NAC) in patients with locally advanced breast cancer (LABC) …

Background Neoadjuvant chemotherapy (NAC) is the standard of care for patients with
locally advanced breast cancer (LABC). The study was conducted to investigate the utility of …

Rationale and Objectives There are limited data on pretreatment imaging features that can
predict response to neoadjuvant chemotherapy (NAC). To extract volumetric pretreatment …